J4 ›› 2010, Vol. 9 ›› Issue (2): 33-34.

Previous Articles     Next Articles

An Analysis of 43 Cases of Graves Disease Treated with 131I

  

  1. Department of Nuclear Medicine, Dali Affiliated Hospital,Dali University, Dali, Yunnan 671000, China
  • Received:2009-06-05 Revised:2009-10-21 Online:2010-02-15 Published:2010-02-15

Abstract:

Objective: To analyze the results of the treatment of 131I therapy for Graves disease in this region. Methods: 43 cases of Graves disease were treated with 131I-based integrated treatment and regular follow-up was accompanied to evaluate the efficacy after treatment. Results: No adverse reactions occurred in the early period. In the follow-up from 4 to 19 months, 27 cases were cured, the cure rate being 62.8%; there was significant improvement in 15 cases, efficiency being 97.7%; 1 case is invalid, ineffective rate being 2.3%. The thyroid volume was significantly reduced. Conclusion: It is safe and effective to treat Graves disease with 131I therapy, and it has a good application prospect.

Key words: Graves disease, hyperthyroidism, 131I therapy

CLC Number: